We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • Tissue Regenix in development mode

    31 October 2014

    Medical devices company Tissue Regenix is looking to build on the success of its product launch in the US this year
  • Speculation builds over Pfizer return

    31 October 2014

    Pfizer chief execuitve Ian Read has come to the defence of tax inversion deals, prompting speculation it will reapproach AstraZeneca.
  • GSK plans HIV float

    31 October 2014

    Drugs giant GlaxoSmithKline (GSK) is considering the float of a minority stake in its shared HIV business ViiV Healthcare.
  • Epistem prepares for launch

    28 October 2014

    Epistem has filed its application with Indian regulators to approve its Genedrive diagnostics product for tuberculosis
  • Shire takeover collapses

    16 October 2014

    AbbVie's high-profile takeover of specialty pharma group Shire has fallen through.
  • Shire takeover under threat

    15 October 2014

    Abbvie has said it will reconsider its mega-takeover of Shire in light of new US tax regulation.

Register today and get...

Register today and get...
Please note terms & conditions apply